Lataa...

Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays

BACKGROUND: Patients with severe hemophilia A and inhibitors are at risk of bleeding during invasive procedures. The standard of care for preventing perioperative bleeding has been replacement therapy with FVIII concentrates or for patients with high-titer inhibitors, bypassing agents. However, ther...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ther Adv Hematol
Päätekijät: Kizilocak, Hande, Yukhtman, Clara Lana, Marquez-Casas, Elizabeth, Lee, Jeanie, Donkin, Jennifer, Young, Guy
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6598318/
https://ncbi.nlm.nih.gov/pubmed/31275538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620719860025
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!